عرض بسيط للتسجيلة

المؤلفAzar, S.
المؤلفHasan, Anwarul
المؤلفYounes, R.
المؤلفNajdi, F.
المؤلفBaki, L.
المؤلفGhazale H.
المؤلفKobeissy F.H.
المؤلفZibara, K.
المؤلفMondello, S.
تاريخ الإتاحة2022-05-21T10:18:33Z
تاريخ النشر2017
اسم المنشورMethods in Molecular Biology
المصدرScopus
المعرّفhttp://dx.doi.org/10.1007/978-1-4939-6952-4_3
معرّف المصادر الموحدhttp://hdl.handle.net/10576/31330
الملخصTraumatic brain injury (TBI) is an injury to the brain caused by an external mechanical force, affecting millions of people worldwide. The disease course and prognosis are often unpredictable, and it can be challenging to determine an early diagnosis in case of mild injury as well as to accurately phenotype the injury. There is currently no cure for TBI?drugs having failed repeatedly in clinical trials?but an intense effort has been put to identify effective neuroprotective treatment. The detection of novel biomarkers, to understand more of the disease mechanism, facilitates early diagnosis, predicts disease progression, and develops molecularly targeted therapies that would be of high clinical interest. Over the last decade, there has been an increasing effort and initiative toward finding TBI-specific biomarker candidates. One promising strategy has been to use state-ofthe- art neuroproteomics approaches to assess clinical biofluids and compare the cerebrospinal fluid (CSF) and blood proteome between TBI and control patients or between different subgroups of TBI. In this chapter, we summarize and discuss the status of biofluid proteomics in TBI, with a particular focus on the latest findings.
اللغةen
الناشرHumana Press Inc.
الموضوعBiomarkers
Blood
Brain injury
Clinical practice
CSF
Diagnosis
Monitoring
Neuroproteomics
Outcome
Proteomics
TBI
العنوانBiofluid proteomics and biomarkers in traumatic brain injury
النوعBook chapter
رقم المجلد1598
dc.accessType Abstract Only


الملفات في هذه التسجيلة

الملفاتالحجمالصيغةالعرض

لا توجد ملفات لها صلة بهذه التسجيلة.

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة